Opioid Prescribing: Leveraging the Newest CDC Clinical Guidelines for Better Decision-Making and Documentation
In November 2022, the CDC published an updated Clinical Practice Guidelines for Prescribing Opioids for Pain. The new CDC material contains 12 recommendations and associated implementation considerations focusing on four main topics: (1) whether to initiate opioid therapy, (2) drug and dose selection, (3) duration of initial opioid therapy and conducting follow-up, and (4) risk mitigation strategies. The CDC materials ARE voluntary and ARE NOT legally mandated. Nevertheless, main street practitioners need to understand how the CDC materials relate to their professional licensing board rules and guidelines, and how to incorporate CDC implementation considerations into patient encounters and medical record documentation. Using sample patient encounters, attendees will examine all 12 CDC recommendations, evaluate how to relate them to their state licensing board material, and use them to individualize patient care and improve medical record documentation. As part of this course, attendees will be provided a quick reference guide to support the review of their charting practices with the goal of improving their documentation of opioid prescribing considerations to actively demonstrate quality patient pain care.
Jennifer Bolen, JD
The J. Bolen Group, LLC
Lenoir City, TN
Jennifer Bolen, JD, is the founder and owner of the J Bolen Group, LLC d/b/a the Legal Side of Pain. She is an actively licensed attorney and a former federal prosecutor. Ms. Bolen has nearly 20 years of experience in legal, regulatory, and compliance matters impacting pain medicine, addiction treatment, and clinical toxicology. Ms. Bolen frequently serves as a subject matter expert to attorneys and law firms nationwide on legal matters impacting physicians, nurse practitioners, and clinical laboratory owners. Ms. Bolen proudly serves PainWeek and its attendees and looks forward to engaging attendees in discussions designed to guide daily practice and proactive business and practice compliance measures.